18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

United States

MD Anderson Cancer Center, Houston, Texas